About
Science
Pipeline
Jobs
News
News
Read the latest from HI-Bio™
All
Press Releases
October 31, 2023
HI-Bio Announces Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration for Primary Membranous Nephropathy (PMN)
Press Releases
October 13, 2023
HI-Bio to Present at the American Society of Nephrology Kidney Week 2023 Annual Meeting
Press Releases
July 11, 2023
HI-Bio Initiates Healthy Volunteer Study of HIB210 for Immune-Mediated Diseases
Press Releases
May 25, 2023
HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Membranous Nephropathy
Press Releases
April 18, 2023
HI-Bio Appoints Industry Veterans Uptal Patel, M.D., as Chief Medical Officer and Sunil Agarwal, M.D., as Board Member
Press Releases
April 11, 2023
HI-Bio Announces Positive Phase 2 Data on Felzartamab for the Treatment of Primary Membranous Nephropathy
News
April 11, 2023
Fierce Biotech: HI-Bio's expectations elevated after pair of phase 2 readouts bolster autoimmune ambitions
News
November 1, 2022
BioPharma Dive: Armed with $120M, HI-Bio joins race to develop better autoimmune disease drugs
1
2
Contact Us
info@hibio.com